CNTNAP2
CNTNAP2 (contactin associated protein 2), also known as Caspr2, KIAA0868 and NRXN4, is a neurexin-family cell adhesion molecule and receptor of the vertebrate nervous system. It is localised at the juxtaparanodes of myelinated axons and supports neuron–glia interactions during development. Browse Assay Genie's current range of CNTNAP2 research reagents below, or read on for the biology behind the target.
CNTNAP2 belongs to the neurexin family, whose members act in the vertebrate nervous system as cell adhesion molecules and receptors. The protein is required, together with CNTNAP1, for the radial and longitudinal organisation of myelinated axons. It contributes to the formation of functionally distinct axonal domains that are critical for saltatory conduction of nerve impulses in myelinated fibres, and it demarcates the juxtaparanodal region of the axo-glial junction. It is also reported to be required for gap junction formation. In the nervous system it mediates interactions between neurons and glia during development and is involved in localising potassium channels within differentiating axons.
Like other neurexin proteins, Caspr2 contains epidermal growth factor repeats and laminin G domains. It additionally carries an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. UniProt lists its locations as membrane, axon, and the paranodal septate junction. Researchers studying the CNTNAP2 gene or the CNTNAP2 protein often work in the context of myelinated axon organisation and axonal ion channel distribution.
The CNTNAP2 gene is one of the largest in the human genome, encompassing almost 1.5% of chromosome 7. It is directly bound and regulated by forkhead box protein P2 (FOXP2), a transcription factor related to speech and language development. The gene has been implicated in several neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. HGNC places it in the contactin associated protein family, and its previous name was contactin associated protein like 2.
CNTNAP2 is needed, with CNTNAP1, for radial and longitudinal organisation of myelinated axons and for demarcating the juxtaparanodal region.
As a neurexin-family adhesion molecule and receptor, it mediates contacts between neurons and glia during nervous system development.
The protein is involved in localising potassium channels within differentiating axons, relevant to saltatory conduction.
The gene is implicated in Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability, and is regulated by FOXP2.
CNTNAP2 is a neurexin-family cell adhesion molecule and receptor. It is required, with CNTNAP1, for organisation of myelinated axons, helps form the domains needed for saltatory conduction, and marks the juxtaparanodal region of the axo-glial junction. It also contributes to potassium channel localisation in developing axons.
CNTNAP2 is also called Caspr2, KIAA0868 and NRXN4. UniProt names the protein contactin-associated protein-like 2, and HGNC lists the previous name contactin associated protein like 2. It sits in the contactin associated protein family alongside CNTNAP1 and CNTNAP3.
The CNTNAP2 gene has been implicated in Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. A mouse ortholog, Cntnap2, exists. Check the datasheet of any product for its validated reactivity.
Other contactin associated protein family members that act in myelinated axon organisation and neuron–glia signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UHC6; product specifications from Assay Genie datasheets.